Track the most important health care lawsuits facing U.S. courts today.



September 18, 2023 | Several amicus briefs are filed – by Medicare experts, economists, patient advocates, and U.S. Senators – supporting the federal government’s efforts to defend the constitutionality of the Inflation Reduction Act’s prescription drug price negotiation program.
This important alert links to ‘Merck v. Becerra et al.’How the Litigation Tracker Works
-
Search for a lawsuit or issue More than 125 cases over 14 issues
-
Explore related documentation Extensive library of key filing documents
-
Learn the current status of the case Realtime case updates
-
Read our analysis Read our take on the most pressing cases
Issues We’re Tracking

Our Team
We’re lawyers who speak and write like non-lawyers.
We’re the experts on health care litigation. We’re here to make the process of navigating and understanding health care litigation easy.

Katie Keith, J.D., M.P.H.
On public service leave from the O’Neill Institute where she is director of the Health Policy and the Law Initiative

Andrew J. Twinamatsiko
Associate director of the Health Policy and the Law Initiative at the O’Neill Institute

Zach Baron
Associate director of the Health Policy and the Law Initiative at the O’Neill Institute
Latest Updates
Key Dates
Plaintiffs’ Response to Motion to Dismiss Due
Plaintiffs’ Motion for Leave to Amend Complaint Due
Plaintiff’s Summary Judgment Motion Due
Plaintiff’s Summary Judgment Motion Due
Government’s Response and Reply Brief Due
Amended Pleadings Due
Defendants’ Rebuttal in Support of Cross-Motion for Summary Judgment Due
Case Management Conference and Motion Hearing
Government’s Combined Opposition and Cross-Motion for Summary Judgment Due
Government’s Combined Opposition and Cross-Motion for Summary Judgment Due
Government’s Reply Brief Due
Plaintiff’s Combined Reply in Support of Summary Judgment Motion Due
Status Report Due
Government’s Reply Brief Due
Joint Status Report Due
Initial Scheduling Conference
Plaintiffs’ Summary Judgment Due
In the News
• Health Affairs
What’s The Nondelegation Doctrine Got To Do With Drug Price Negotiation?
• O’Neill Institute
Latest Twists and Turns in No Surprises Act Litigation: What it Means for Consumers and Ongoing Implementation
• O’Neill Institute
Policy Dispute Masquerading As Constitutional Theory? Due Process Attacks on Medicare Drug Negotiation Program
• MedPage